Abstract:BACKGROUND: Rupture of intracranial aneurysm (IA) is the leading cause of subarachnoid hemorrhage. However, there are few pharmacological therapies available for the prevention of IA rupture. Therefore, exploring the molecular mechanisms which underlie IA rupture and identifying the potential molecular targets for preventing the rupture of IA is of vital importance.METHODS: We used the Gene Expression Omnibus (GEO) datasets GSE13353, GSE15629, and GSE54083 in our study. The 3 datasets were merged and normalized. Differentially expressed gene (DEG) screening and weighted correlation network analysis (WGCNA) were conducted. The co-expression patterns between ruptured IA samples and unruptured IA samples were compared. Then, the DEGs were mapped into the whole co-expression network of ruptured IA samples, and a DEG co-expression network was generated. Molecular Complex Detection (MCODE) (http://baderlab.org/Software/MCODE) was used to identify key genes based on the DEG co-expression network. Finally, key genes were validated using another GEO dataset (GSE122897), and their potential diagnostic values were shown using receiver operating characteristic (ROC) analysis.RESULTS: In our study, 49 DEGs were screened while 8 and 6 gene modules were detected based on ruptured IA samples and unruptured IA samples, respectively. Pathways associated with inflammation and immune response were clustered in the salmon module of ruptured IA samples. The DEG co-expression network with 35 nodes and 168 edges was generated, and 14 key genes were identified based on this DEG co-expression network. The gene with the highest degree in the key gene cluster was CXCR4. All key genes were validated using GSE122897, and they all showed the potential diagnostic value in predicting IA rupture.CONCLUSIONS: Using a weighted gene co-expression network approach, we identified 8 and 6 modules for ruptured IA and unruptured IA, respectively. After that, we identified the hub genes for each module and key genes based on the DEG co-expression network. All these key genes were validated by another GEO dataset and might serve as potential targets for pharmacological therapies and diagnostic markers in predicting IA rupture. Further studies are needed to elucidate the detailed molecular mechanisms and biological functions of these key genes which underlie the rupture of IA.

Exploration of the shared gene signatures and molecular mechanisms between Alzheimer's disease and intracranial aneurysm

Identifying Shared Diagnostic Genes and Mechanisms in Vascular Dementia and Alzheimer's Disease Via Bioinformatics and Machine Learning

Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms

Identification and Validation of TREM2 in Intracranial Aneurysms

Integrative bioinformatics analysis of miRNA and mRNA expression profiles and identification of associated miRNA-mRNA network in intracranial aneurysms

Bioinformatics analysis reveals potential biomarkers associated with the occurrence of intracranial aneurysms

Identifying and validating key genes mediating intracranial aneurysm rupture using weighted correlation network analysis and exploration of personalized treatment

Expression Profile Analysis of Differentially Expressed Genes in Ruptured Intracranial Aneurysms: in Search of Biomarkers.

Bioinformatic analysis of gene expression profiling of intracranial aneurysm.

Identification of Hub Genes Associated with the Pathogenesis of Intracranial Aneurysm via Integrated Bioinformatics Analysis

Screening of Key Genes of Unruptured Intracranial Aneurysms by Using DNA Microarray Data Analysis Techniques.

Identification and validation of key genes mediating intracranial aneurysm rupture by weighted correlation network analysis

Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics

The pathogenesis shared between abdominal aortic aneurysms and intracranial aneurysms: a microarray analysis

Genetic Profiles Related to Pathogenesis in Sporadic Intracranial Aneurysm Patients

Screening of Critical Genes and MicroRNAs in Blood Samples of Patients with Ruptured Intracranial Aneurysms by Bioinformatic Analysis of Gene Expression Data.

MicroRNA/mRNA Profiling and Regulatory Network of Intracranial Aneurysm

Identification of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Intracranial Aneurysm.

Global Gene Expression Patterns and Somatic Mutations in Sporadic Intracranial Aneurysms

Identification and Verification of the Oxidative Stress-Related Signature Markers for Intracranial Aneurysm-Applied Bioinformatics

Aberrant expression of lncRNAs and mRNAs in patients with intracranial aneurysm.